Article

AJMC® in the Press, February 1, 2019

Author(s):

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study published in The American Journal of Managed Care® (AJMC®) was highlighted in an article from mHealth Intelligence. The study, “A Cost-Effectiveness Analysis of Cardiology eConsults for Medicaid Patients,” found that a randomized trial of eConsults for cardiology referrals from primary care resulted in significant reductions in total cost of care compared with traditional fee-for-service consultations.

The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included an editorial published in the February 2019 issue of AJMC®. The editorial, “The Drug Pricing Iceberg: More Than Meets the Eye,” argues that policies that reduce prices but do not lower consumers’ out-of-pocket costs will not address the main challenge facing most Americans. The editorial was also featured in a press release from the University of Michigan’s Center for Value-Based Insurance Design, which is directed by A. Mark Fendrick, MD, the editorial’s lead author and co-editor-in-chief of AJMC®.

ADVANCE’s article on virtual visits focused on a study published in the January issue of AJMC®, “Patient and Clinician Experience With Telehealth for Patient Follow-up Care,” which demonstrated that for established patients, virtual video visits can be used for effective follow-up and enhanced convenience when compared with traditional office visits.

An article from Mind Body Green on yoga cited the AJMC® article “Restorative Yoga Better Than Stretching for Trimming Subcutaneous Fat in Overweight Women.” The article covered a session from the 73rd Scientific Sessions of the American Diabetes Association on a study showing that restorative yoga practitioners lost significantly more subcutaneous fat over the initial 6 months of the study period and kept losing it during a maintenance period with less direct supervision.

OBR Oncology’s Monday newsfeed included an article from AJMC®’s sister site, The Center for Biosimilars® (CfB). The article, “More Research Finds Low Awareness of Biosimilars Among Oncology Providers,” covered a survey that found that while a majority of respondents said they were at least somewhat familiar with current developments in oncology biosimilars, analyses of open-ended definitions showed that just 1 respondent could fully define a biosimilar. A second newsfeed included the CfB article “Sales of Oncology Reference Products Far Outpace R&D Costs, Study Finds,” which covered a study that found some stakeholders have expressed skepticism about whether research and development costs are indeed in line with the prices that drug makers charge.

Related Videos
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Neal D. Shore, MD
Amit Singal, MD, UT Southwestern Medical Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo